Ocugen, Inc.
OCGN
$1.24
-$0.02-1.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.51% | -125.26% | 54.23% | 20.33% | 46.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.51% | -125.26% | 54.23% | 20.33% | 46.06% |
| Cost of Revenue | 43.64% | 28.70% | 37.51% | -5.62% | -88.49% |
| Gross Profit | -41.87% | -44.33% | -34.78% | 9.43% | 111.96% |
| SG&A Expenses | 25.79% | -2.87% | 31.02% | -11.99% | 0.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -8,676.92% | 132,000.00% | -- | -- |
| Total Operating Expenses | 21.21% | 7.33% | 43.85% | -8.57% | 20.80% |
| Operating Income | -23.02% | -14.66% | -42.96% | 10.71% | -18.70% |
| Income Before Tax | -24.93% | -27.56% | -54.60% | 3.54% | -28.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.93% | -27.56% | -54.60% | 3.54% | -28.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.93% | -27.56% | -54.60% | 3.54% | -28.73% |
| EBIT | -23.02% | -14.66% | -42.96% | 10.71% | -18.70% |
| EBITDA | -24.04% | -15.33% | -42.38% | 13.47% | -15.53% |
| EPS Basic | -11.22% | -18.87% | -41.63% | 14.84% | -13.61% |
| Normalized Basic EPS | -11.25% | -18.79% | -41.58% | 15.09% | -13.45% |
| EPS Diluted | -11.22% | -18.87% | -41.63% | 14.84% | -13.61% |
| Normalized Diluted EPS | -11.25% | -18.79% | -41.58% | 15.09% | -13.45% |
| Average Basic Shares Outstanding | 12.17% | 7.36% | 9.29% | 13.49% | 13.51% |
| Average Diluted Shares Outstanding | 12.17% | 7.36% | 9.29% | 13.49% | 13.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |